Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 152 recruiting now full pipeline #8 of 28,707 conditions

Hypertension: full-pipeline trial registry

152 of 472 indexed Hypertension trials are currently recruiting.

Corpus placement: #8 of 28,707 conditions by registered trial count.

472 US clinical trials · 152 currently recruiting · #8 of 28,707 conditions by registered trial count

Hypertension: 472 US clinical trials tracked, 152 recruiting.

Hypertension is the subject of 472 registered US clinical trials on ClinicalTrials.gov, 152 of them currently open to new participants. 65 are in Phase 3-4 (later-stage) and 64 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 15 of these trials.

Enrollment posture brief

Registry condition hypertension

OPEN 152 | RECR 32% | LATE 65 | EARLY 64 | RANK #8 | SPON 15

Nearest open-share peer: Leukemia, Myeloid, Acute (32% recruiting · 31 trials)

Stroke47.8%Non-Small Cell Lung Cancer45.3%Multiple Myeloma37.9%Lung Cancer34%Hypertension (this)32%
Open-enrollment share among volume-matched conditions near Hypertension

Hypertension lists 152 open slots (32% of 472 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hypertension is recruiting below its size-band peers.

    152 of 472 indexed trials (32.2%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hypertension trials is spread across many organizations.

    Johns Hopkins University accounts for 15 of 472 trials (3.2%). 195 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hypertension enrolment sits around 168 participants.

    Median target enrolment is 168 among the 471 trials that report a genuine target (sentinel values excluded). 170 of those (36.1%) plan for fewer than 100 participants.

  4. Hypertension research is mostly interventional.

    407 interventional and 65 observational studies make up this index (86.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 139Phase 225Phase 337Phase 428

Open and recent trials

472 total, page 3 of 10

RECRUITING NA 100 participants

HTN App for HTN Control and Cardiovascular Health Among African-Americans

Mayo Clinic

NCT06346886

RECRUITING Early Phase 1 100 participants

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

University of Texas Southwestern Medical Center

NCT04838678

RECRUITING NA 100 participants

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

University of Texas Southwestern Medical Center

NCT05168605

RECRUITING 100 participants

Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy

Mayo Clinic

NCT06886087

RECRUITING Phase 4 100 participants

Secondhand Tobacco Smoke and Cardiovascular Disease

University of California, San Francisco

NCT04715568

RECRUITING NA 95 participants

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

West Virginia School of Osteopathic Medicine

NCT06049420

RECRUITING 91 participants

Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

Dynocardia

NCT04835857

RECRUITING NA 90 participants

Inspire HER: Inspiring the Heart and Emotions for Radical Health

University of Alabama at Birmingham

NCT06966258

RECRUITING NA 90 participants

Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise

University of Colorado, Boulder

NCT05000515

RECRUITING NA 80 participants

MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Clinical Nutrition Research Center, Illinois Institute of Technology

NCT06555952

RECRUITING Early Phase 1 80 participants

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

University of Minnesota

NCT06507657

RECRUITING NA 80 participants

Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes

Johns Hopkins University

NCT06921356

RECRUITING NA 80 participants

Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension

University of Massachusetts, Boston

NCT06554340

RECRUITING NA 80 participants

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

University of Alabama at Birmingham

NCT05556902

RECRUITING NA 80 participants

Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health

Skidmore College

NCT06363305

RECRUITING NA 79 participants

AM vs PM Exercise Training

Michigan State University

NCT06042439

RECRUITING Phase 4 75 participants

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Brigham and Women's Hospital

NCT05593055

RECRUITING NA 72 participants

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

University of Connecticut

NCT07238556

RECRUITING Phase 1 70 participants

Targeting Endoplasmic Reticulum Stress in Human Hypertension

University of North Texas Health Science Center

NCT06025630

RECRUITING NA 70 participants

Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial

Mayo Clinic

NCT06826755

RECRUITING NA 69 participants

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

VA Office of Research and Development

NCT04163614

RECRUITING NA 60 participants

How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes

University of Nevada, Las Vegas

NCT06817252

RECRUITING Phase 4 60 participants

Treatment With Aspirin After Preeclampsia: TAP Trial

Malamo Countouris

NCT06281665

RECRUITING NA 60 participants

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

University of Delaware

NCT07071077

RECRUITING Early Phase 1 52 participants

Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension

Milton S. Hershey Medical Center

NCT06482853

RECRUITING NA 50 participants

Assessing Peer Support for Physical Activity in Women With HIV and Hypertension

University of Alabama at Birmingham

NCT07025109

RECRUITING NA 50 participants

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

Massachusetts General Hospital

NCT07091851

RECRUITING 50 participants

Remote Fetal Monitoring in High Risk Pregnancies

Beth Israel Deaconess Medical Center

NCT06822439

RECRUITING NA 50 participants

Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor

Stanford University

NCT05730465

RECRUITING 50 participants

Imaging the Pathogenesis of Cerebral Small Vessel Disease

Johns Hopkins University

NCT05703386

RECRUITING Early Phase 1 46 participants

Reversing Glucose and Lipid-mediated Vascular Dysfunction

University of Kansas Medical Center

NCT04832009

RECRUITING NA 46 participants

Community-based Implementation of Adapted STAC

University of Wisconsin, Madison

NCT06689930

RECRUITING NA 44 participants

Sleep Restriction and Parental History of Hypertension

Mayo Clinic

NCT06482814

RECRUITING Phase 4 40 participants

Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

Brigham and Women's Hospital

NCT05030545

RECRUITING NA 35 participants

Ketone Ester and Salt (KEAS) in Young Adults

Indiana University

NCT05545501

RECRUITING NA 32 participants

Sleep and Circadian Mechanisms in Hypertension

Oregon Health and Science University

NCT05184933

RECRUITING NA 30 participants

Ketone Ester And Salt (KEAS) in Older Adults

Indiana University

NCT06868719

RECRUITING NA 30 participants

Early Time-Restricted Eating in Older Adults With Hypertension

University of Alabama at Birmingham

NCT07135505

RECRUITING NA 30 participants

Examining the Circadian Timing Effects of the Hypotensive Response to Exercise

Freda Patterson

NCT07049783

RECRUITING NA 30 participants

Remote Vinyasa Yoga Program for Heart Health

West Virginia University

NCT06961981

RECRUITING Phase 1 26 participants

Metabolic Effects of Angiotensin-(1-7)

Vanderbilt University

NCT02646475

RECRUITING NA 25 participants

Improving Hypertension Control in Rheumatoid Arthritis

Duke University

NCT05760898

RECRUITING Early Phase 1 24 participants

Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

Benjamin Viglianti

NCT04546126

RECRUITING NA 24 participants

Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors

University of Illinois at Chicago

NCT06504914

RECRUITING Phase 1 23 participants

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

University of Kansas Medical Center

NCT04715022

RECRUITING NA 20 participants

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

Indiana University

NCT07119658

RECRUITING NA 20 participants

Supporting VETerans With Kidney Disease Through Food As Medicine

VA Eastern Colorado Health Care System

NCT07194733

RECRUITING NA 20 participants

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Vanderbilt University Medical Center

NCT03042988

RECRUITING NA 20 participants

Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )

Wake Forest University

NCT06375694

RECRUITING Phase 1 12 participants

Sympathetic Mechanisms in Obesity-Crossover Design

Vanderbilt University Medical Center

NCT05312892

← Previous Page 3 of 10 Next →

Phase Distribution

PhaseTrial count
Phase 1 39
Phase 2 25
Phase 3 37
Phase 4 28

Named interventions

Most-linked intervention names on Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
30 trials
Amlodipine Drug
7 trials
Nebivolol Drug
5 trials
Eplerenone Drug
4 trials
Valsartan Drug
4 trials
Ramipril Drug
4 trials
Usual care Other
4 trials
Saline Drug
4 trials

US sites by state

Facility locations filed on Hypertension trials. A trial with sites in several states counts in each.

California 84 trials
Florida 53 trials
Massachusetts 49 trials
New York 47 trials
Illinois 47 trials
Alabama 43 trials
North Carolina 41 trials
Maryland 40 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hypertension page

472 registered trials, 152 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertension condition card totals 472 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.